(S)-tert-Butyl 2-(hydroxymethyl)-2,5-dihydro-1H-pyrrole-1-carboxylate, 97%, 5g

Methanone, phenyl-2-pyridinyl-, 2-(5-chloro-2-pyridinyl)hydrazone, (E,E)-, 98%, 1g

4-Amylcyclohexylamine (cis- and trans- mixture)>98.0%(GC)(T)5mL

Metadoxine, 99.38%, 5g

1,2-Dimethyl-3-fluoro-4-iodobenzene, 95.0%, 10g

({[1,1'-biphenyl]-4-yl}methyl)(prop-2-en-1-yl)amine, 95.0%, 2g

Dialysis membrane Spectra/Por® Biotech CE MWCO 3500–5000, 10 mm, 1 Piece(s)

3-Bromo-4-methylbenzaldehyde, 95.0%, 25g

N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N2-(2-((5-sulfonaphthalen-1-yl)amino)ethyl)-L-asparagine, 95%, 1g

H-Ser(tBu)-OtBu HCl, 95.0%, 100g

Acetic acid, min. 99%, for synthesis, 5 l, plastic packaging.

(S)-3-AMINO-2,3-DIHYDRO-1H-INDEN-5-OL HCL, 95.0%, 100mg

3-Fluoro-2-methoxybenzoic acid, 98.0%, 10g